Chitosan oligosaccharides prevented retinal ischemia and reperfusion injury via reduced oxidative stress and inflammation in rats
- PMID: 25479043
- DOI: 10.1016/j.exer.2014.12.001
Chitosan oligosaccharides prevented retinal ischemia and reperfusion injury via reduced oxidative stress and inflammation in rats
Abstract
The purpose of the present study was to investigate the protective effect and mechanism of chitosan oligonucleotides (COS) on retinal ischemia and reperfusion (I/R) injury. Rats pretreated with PBS, low-dose COS (5 mg/kg), or high-dose COS (10 mg/kg) were subjected to retinal ischemia by increasing their intraocular pressure to 130 mm Hg for 60 min. The protective effect of COS was evaluated by determining the electroretinograms (ERGs), morphology of the retina, and survival of retinal ganglion cells (RGCs). The oxidative damage was determined by imuunohistochemistry and ELISA, respectively. The expressions of inflammatory mediators (TNF-α, IL-1β, MCP-1, iNOS, ICAM-1) and apoptotic-related proteins (p53, Bax, Bcl-2) were quantified by PCR and Western blots. The detection of NF-κB p65 in the retina was performed by immunofluorescence. The protein levels of IκB and phosphorylated mitogen-activated protein kinases [MAPK; viz. extracellular signal-regulated protein kinases (ERK), c-Jun N-terminal kinases (JNK) and p38] and the NF-κB/DNA binding ability were assessed by Western blot analysis and EMSA. We found that pretreatment with COS, especially a high dosage, effectively ameliorated the I/R-induced reduction of the b-wave ratio in ERGs and the retinal thickness and the survival of RGCs at 24 h. COS decreased the expression of inflammatory mediators, p53 and Bax, increasing Bcl-2 expression and thereby reducing retinal oxidative damage and the number of apoptotic cells. More importantly, COS attenuated IκB degradation and p65 presence in the retina, thus decreasing NF-κB/DNA binding activity after I/R. In addition, COS decreased the phosphorylation levels of JNK and ERK but increased the phosphorylation level of p38. Pretreatment with p38 inhibitor (SB203580) abolished the protective effect of COS on retinal oxidative damage, as indicated by increased retinal 8-OHdG stains, and significantly increased the expression of inflammatory mediators (TNF-α, MCP-1, iNOS, ICAM-1) in I/R-injured rats. In conclusion, COS prevented retinal I/R injury through its inhibition of oxidative stress and inflammation. These effects were achieved by blocking the activation of NF-κB, JNK, and ERK but promoting the activation of p38 activation.
Keywords: Chitosan oligosaccharides; Ischemia-reperfusion injury; Mitogen-activated protein kinases (MAPK); NF-κB; Oxidative damage.
Copyright © 2014 Elsevier Ltd. All rights reserved.
Similar articles
-
Protective effect of pioglitazone on retinal ischemia/reperfusion injury in rats.Invest Ophthalmol Vis Sci. 2013 Jun 6;54(6):3912-21. doi: 10.1167/iovs.13-11614. Invest Ophthalmol Vis Sci. 2013. PMID: 23557740
-
Chitosan oligosaccharides attenuates oxidative-stress related retinal degeneration in rats.PLoS One. 2013 Oct 14;8(10):e77323. doi: 10.1371/journal.pone.0077323. eCollection 2013. PLoS One. 2013. PMID: 24155943 Free PMC article.
-
Preconditioning with inhalative carbon monoxide protects rat retinal ganglion cells from ischemia/reperfusion injury.Invest Ophthalmol Vis Sci. 2010 Jul;51(7):3784-91. doi: 10.1167/iovs.09-4894. Epub 2010 Feb 24. Invest Ophthalmol Vis Sci. 2010. PMID: 20181836
-
Protective effects of gastrin-releasing peptide receptor antagonist RC-3095 in an animal model of hepatic ischemia/reperfusion injury.Hepatol Res. 2019 Mar;49(3):247-255. doi: 10.1111/hepr.13315. Epub 2019 Feb 7. Hepatol Res. 2019. PMID: 30656798 Review.
-
Ameliorating effects of traditional Chinese medicine preparation, Chinese materia medica and active compounds on ischemia/reperfusion-induced cerebral microcirculatory disturbances and neuron damage.Acta Pharm Sin B. 2015 Jan;5(1):8-24. doi: 10.1016/j.apsb.2014.11.002. Epub 2015 Jan 24. Acta Pharm Sin B. 2015. PMID: 26579420 Free PMC article. Review.
Cited by
-
Pharmacological Potential and Synthetic Approaches of Imidazo[4,5-b]pyridine and Imidazo[4,5-c]pyridine Derivatives.Molecules. 2017 Mar 4;22(3):399. doi: 10.3390/molecules22030399. Molecules. 2017. PMID: 28273868 Free PMC article. Review.
-
Chitosan oligosaccharides inhibit IL-1β-induced chondrocyte apoptosis via the P38 MAPK signaling pathway.Glycoconj J. 2016 Oct;33(5):735-44. doi: 10.1007/s10719-016-9667-1. Epub 2016 May 13. Glycoconj J. 2016. PMID: 27178341
-
Recent Updates in Pharmacological Properties of Chitooligosaccharides.Biomed Res Int. 2019 Oct 31;2019:4568039. doi: 10.1155/2019/4568039. eCollection 2019. Biomed Res Int. 2019. PMID: 31781615 Free PMC article.
-
Maternal chitosan oligosaccharide intervention optimizes the production performance and health status of gilts and their offspring.Anim Nutr. 2020 Jun;6(2):134-142. doi: 10.1016/j.aninu.2020.02.001. Epub 2020 Mar 5. Anim Nutr. 2020. PMID: 32542193 Free PMC article.
-
Collagen peptide modified carboxymethyl cellulose as both antioxidant drug and carrier for drug delivery against retinal ischaemia/reperfusion injury.J Cell Mol Med. 2018 Oct;22(10):5008-5019. doi: 10.1111/jcmm.13768. Epub 2018 Jul 20. J Cell Mol Med. 2018. PMID: 30030883 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous
